Bayesian Capital Management’s Xerox XRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-51,400
Closed -$597K 1084
2024
Q2
$597K Buy
+51,400
New +$746K 0.07% 323
2023
Q2
Sell
-13,099
Closed -$202K 1099
2023
Q1
$202K Buy
+13,099
New +$212K 0.03% 615
2021
Q2
Sell
-27,764
Closed -$674K 682
2021
Q1
$674K Buy
+27,764
New +$664K 0.16% 171
2020
Q3
Sell
-67,700
Closed -$1.03M 718
2020
Q2
$1.03M Buy
67,700
+6,400
+10% +$110K 0.23% 122
2020
Q1
$1.16M Buy
61,300
+29,300
+92% +$931K 0.25% 96
2019
Q4
$1.18M Buy
+32,000
New +$1.12M 0.2% 147
2018
Q3
Sell
-22,802
Closed -$547K 826
2018
Q2
$547K Sell
22,802
-19,198
-46% -$543K 0.12% 246
2018
Q1
$1.21M Buy
+42,000
New +$1.29M 0.31% 87

Other funds holding XRX

Bayesian Capital Management's XRX Position: Q3 2024 in Review

Bayesian Capital Management sold out of Xerox (XRX) in Q3 2024, closing a stake of 51,400 shares — an estimated $597K sold.

Bayesian Capital Management first reported a position in XRX in Q1 2018 and held it in 8 quarters. The position peaked at $1.21M in Q1 2018. 288 funds tracked by Wall St. Rank hold XRX as of Q3 2024.

  • Bayesian Capital Management reported no remaining Xerox position as of Q3 2024 after selling out during the quarter.
  • Bayesian Capital Management sold 51,400 Xerox shares in Q3 2024, an estimated $597K.
  • Bayesian Capital Management first reported a position in Xerox in Q1 2018 and held it in 8 quarters.
  • Bayesian Capital Management's Xerox position peaked at $1.21M in Q1 2018.
  • 288 funds tracked by Wall St. Rank held Xerox as of Q3 2024.

Based on Bayesian Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.